التفاصيل البيبلوغرافية
| العنوان: |
Effects of repeated transcranial magnetic stimulation in the dorsolateral prefrontal cortex versus motor cortex in patients with neuropathic pain after spinal cord injury: a study protocol |
| المؤلفون: |
Huang, Maomao, Luo, Xi, Zhang, Chi, Xie, Yu-Jie, Wang, Li, Wan, Tenggang, Chen, Ruyan, Xu, Fangyuan, Wang, Jian-Xiong |
| المساهمون: |
the Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Sichuan Medical Association Project Fund, Research Project of Science and Technology Department of Sichuan Province (, the Research Fund of Southwest Medical University, Special Project of Social work and Health Management of Luzhou Federation of Social Sciences in 2021, Research Fund of Southwest Medical University, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province |
| المصدر: |
BMJ Open ; volume 12, issue 3, page e053476 ; ISSN 2044-6055 2044-6055 |
| بيانات النشر: |
BMJ |
| سنة النشر: |
2022 |
| مصطلحات موضوعية: |
General Medicine |
| الوصف: |
Introduction Neuropathic pain is one of the common complications of spinal cord injuries (SCI), which will slow down the recovery process and result in lower quality of life. Previous studies have shown that repeated transcranial magnetic stimulation (rTMS) of the motor cortex (M1) can reduce the average pain and the most severe pain of neuropathic pain after SCI. The dorsolateral prefrontal cortex (DLPFC) area is a common target of rTMS. Recently, a few studies found that rTMS of DLPFC may relieve the neuropathic pain of SCI. Compared with the M1 area, the efficacy of rTMS treatment in the DLPFC area in improving neuropathic pain and pain-related symptoms in patients with SCI is still unclear. Therefore, our study aims to evaluate the non-inferiority of rTMS in the DLPFC vs M1 in patients with neuropathic pain after SCI, in order to provide more options for rTMS in treating neuropathic pain after SCI. Methods and analysis We will recruit 50 subjects with neuropathic pain after SCI. They will be randomly assigned to the DLPFC- rTMS and M1-rTMS groups and be treated with rTMS for 4 weeks. Except for the different stimulation sites, the rTMS treatment programmes of the two groups are the same: 10 Hz, 1250 pulses, 115% intensity threshold, once a day, five times a week for 4 weeks. VAS, simplified McGill Pain Questionnaire, Spinal Cord Injury Pain Date Set, Pittsburgh Sleep Quality Index and Hamilton Anxiety Scale will be evaluated at baseline, second week of treatment, fourth week of treatment and 4 weeks after the end of treatment. And VAS change will be calculated. Ethics and dissemination The Ethics Committee of the Affiliated Hospital of Southwest Medical University has approved this trial, which is numbered KY2020041. Written informed consent will be provided to all participants after verification of the eligibility criteria. The results of the study will be published in peer-reviewed publications. Trial registration number ChiCTR2000032362. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1136/bmjopen-2021-053476 |
| الإتاحة: |
https://doi.org/10.1136/bmjopen-2021-053476Test |
| حقوق: |
http://creativecommons.org/licenses/by-nc/4.0Test/ |
| رقم الانضمام: |
edsbas.5A6E91E0 |
| قاعدة البيانات: |
BASE |
